Range
4.34 - 4.56
Vol / Avg.
66.3K/178K
Div / Yield
-
52 Wk
3.79 - 13.87
Mkt Cap
42.9M
Payout Ratio
-
Open
4.34
P/E
-
EPS
-0.58
Shares
9.5M
Outstanding
9.5M
Total Float
7.9M
Sector: Health Care.Industry: Health Care Equipment & Supplies
Bellerophon Therapeutics Inc is a clinical-stage biotherapeutics company. The firm develops innovative products combining novel drugs and devices to treat cardiopulmonary diseases. It develops products under its INOpulse platform, which is an extension of the technology that is used in hospitals to deliver continuous-flow inhaled nitric oxide. The company products are aimed at the treatment of different kinds of pulmonary hypertension.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.690-0.580 0.1100
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
BLPHBellerophon Therapeutics4.4%42.9M

Bellerophon Therapeutics Frequently Asked Questions

Q

How do I buy Bellerophon Therapeutics (BLPH) stock?

A

You can purchase shares of Bellerophon Therapeutics (NASDAQ: BLPH) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Bellerophon Therapeutics's (BLPH) competitors?

Q

What is the target price for Bellerophon Therapeutics (BLPH) stock?

A

The latest price target for Bellerophon Therapeutics (NASDAQ: BLPH) was reported by Jefferies on August 11, 2020. The analyst firm set a price target for 19.00 expecting BLPH to rise to within 12 months (a possible 321.29% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Bellerophon Therapeutics (BLPH)?

A

The stock price for Bellerophon Therapeutics (NASDAQ: BLPH) is $4.51 last updated Today at 6:58:22 PM.

Q

Does Bellerophon Therapeutics (BLPH) pay a dividend?

A

There are no upcoming dividends for Bellerophon Therapeutics.

Q

When is Bellerophon Therapeutics (NASDAQ:BLPH) reporting earnings?

A
Bellerophon Therapeutics’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Bellerophon Therapeutics (BLPH) going to split?

A

There is no upcoming split for Bellerophon Therapeutics.

Q

What sector and industry does Bellerophon Therapeutics (BLPH) operate in?

A

Bellerophon Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.